Rockford Daybook: Pritzker in Belvidere, PCI expansion, YouthBuild USA
Don't miss out on the news of day. Here's what's happening around Rockford and beyond.
Source: rrstar.com
Page 25 - Pharma Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharma Services Today - Breaking & Trending Today
Quest Diagnostics Granted FDA Breakthrough Designation for its Adeno-associated virus (AAV) Test
Quest and Sarepta Therapeutics Expand Collaboration to Develop AAV Companion Diagnostics for Sarepta's Gene Therapies SECAUCUS, N.J. and CAMBRIDGE, Mass., Aug. 30, 2023 /PRNewswire/ -- Quest...
Source: marketscreener.com
NeoGenomics (NASDAQ:NEO) Rating Increased to Overweight at Stephens
Stephens upgraded shares of NeoGenomics (NASDAQ:NEO – Free Report) from an equal weight rating to an overweight rating in a report issued on Monday, Marketbeat Ratings reports. The brokerage currently has $18.00 target price on the medical research company’s stock, up from their previous target price of $16.00. Other equities research analysts have also issued […]
Source: modernreaders.com
Capula Management Ltd Purchases Shares of 31,840 NeoGenomics, Inc. (NASDAQ:NEO)
Capula Management Ltd acquired a new stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 31,840 shares of the medical research company’s stock, valued at approximately $554,000. A number of other hedge funds and other institutional […]
Source: dailypolitical.com
Capula Management Ltd Purchases New Shares in NeoGenomics, Inc. (NASDAQ:NEO)
Capula Management Ltd acquired a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 31,840 shares of the medical research company’s stock, valued at approximately $554,000. A number of other institutional investors have also added […]
Source: wkrb13.com